Anavex has been under attack, but its drug therapy, the company, Missling, the small AVXL staff, the science, the scientific board, the patent applications and the patent issuance are all real.
We all know drugs that target amyloid are not working, and it is likely amyloid is not the AZ culprit. Evidence that oxidation/nitration/inflammation is the cause of AZ exists. All of the science behind the development of AVXL therapy may be independently verified. On the other hand, those that attack Anavex avoid discussion of this science as well as discussion that amyloid target therapy is not working.
Missling and his small company staff have done nothing nefarious. The SEC subpoena issue is a red herring as I and others on this board have previously discussed. See my post # 476443 above dated December 31, 2015, for example. See the posts today by IQMike.
The adverse SA articles demonstrate nothing of substance about Anavex as it exists today. They turn away from discussing the science. Instead, they criticize the company because it came from a public shell or they attempt to discredit some third party such as Dr. Dee and use guilt by association tactics.
Jim Cramer, not a fan of mine, said something on NBC News the other night when asked about the stock market declines we have seen this week. His response: “Investors should never panic. There has never been a penny made by panicking.”
If you want to make real money, you should not do what everyone else is doing and follow the herd. Do not worry about simply looking bad. If you worry about that, you will never buy and stick with enough of something that works for it to make much of a difference for the better. Do your DD and do not invest more than you can afford to lose. Do not use margin.
I believe that real money, however, may be made by investing in something that is revolutionary in contrast to what everyone else has invested. AVXL engaged in development of a badly needed drug therapy that may revolutionize the treatment or cure of dreaded diseases that afflict our aging population and that is a huge market that is its focus. It is coming along at a time too when the world is grappling with containing escalating health care costs, and governments around the world need to cut spending to deal with their debt burdens.
Anything can fail or succeed. We will have our setbacks, but there are many reasons to believe that Anavex 2-73 (and other Anavex drug therapy) works. The adverse articles we have seen do not scientifically demonstrate that Anavex therapy does not work. The purpose of the clinical trails is to prove that this therapy works. It is up to the clinical trials and the FDA to make the determinations that this drug is safe, it has efficacy, and that it should be approved in the U. S.
Additionally, it may be more easily approved in foreign countries such as Japan, Australia, Israel, Canada and other countries. Lastly, if the drug is approved in any of the aforementioned countries it may be granted reciprocity in the U.S. if this law introduced in Congress passes: “Reciprocity Ensures Streamlined Use of Lifesaving Treatments ACT (S. 2388) or the RESULT ACT is passed by the U. S. Congress.
Stay focused, ignore the noise, do not panic, and give Anavex some time to prove itself!
